A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer

Clinical trial NCT00171704 · COMPLETED

Trial details

NCT number: NCT00171704
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women

Start date: 2005-04-01
Primary completion: 2011-03-01
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.